These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2652468)

  • 1. Effects of cyclosporin on nuclear function of transplant recipient lymphocytes.
    Citterio F; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1465-6. PubMed ID: 2652468
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear effects of cyclosporine.
    Citterio F; Chiocca AE; Kahan BD
    Transplant Proc; 1990 Aug; 22(4):1742-3. PubMed ID: 1697119
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity of the nuclear effect of cyclosporine on the immune cells.
    Citterio F; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):842-3. PubMed ID: 2705247
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression failure: a function of lymphocyte steroid and cyclosporin resistance.
    House AK; Potter JM; Pedersen KE; Kinnear BF; Walker KB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1573-4. PubMed ID: 2652511
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
    Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cyclosporine on nuclear function.
    Citterio F; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):75-9. PubMed ID: 3363668
    [No Abstract]   [Full Text] [Related]  

  • 7. B lymphocytes from stable renal transplant patients do not respond to exogenous lymphokines: comparison of azathioprine and cyclosporin treated patients.
    Weissgarten J; Ng C; Freidman E; Cardella CJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):393-4. PubMed ID: 2650158
    [No Abstract]   [Full Text] [Related]  

  • 8. Resting lymphocytes are the target of cyclosporin action.
    Kimball PM; Gamaz N; Sell S
    Diabetes Res; 1988 Mar; 7(3):113-6. PubMed ID: 3262027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy.
    Hamilton G; Mühlbacher F; Steininger R; Havel M; Kreuzer S; Laengle F; Piza F
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased risk of rejection in renal transplant recipients with in vitro cyclosporin-resistant lymphoid responses.
    Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1470-1. PubMed ID: 2523587
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivity of peripheral blood lymphocytes to recombinant interleukin-2 in kidney transplant recipients.
    Koda N; Oda T; Yokoyama M; Matsumoto A; Takeuchi M
    Transplant Proc; 1990 Oct; 22(5):2373-5. PubMed ID: 2219405
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific immunological tolerance/optimal graft function in the absence of immunosuppressive therapy.
    Burrows L; Reisman L; Schanzer H; Kupfer S
    Transplant Proc; 1989 Feb; 21(1 Pt 1):369-72. PubMed ID: 2539670
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and function of a major OKT3, OKT8, Leu-7, positive lymphocyte subpopulation in renal transplant recipients treated with total lymphoid irradiation.
    Waer M; Vanrenterghem Y; Van der Schueren E; Michielsen P; Vandeputte M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1570-1. PubMed ID: 3079027
    [No Abstract]   [Full Text] [Related]  

  • 14. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J; Masramon J; Orfila A; Cuevas X; Aubia J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract]   [Full Text] [Related]  

  • 15. T suppressor cell function in cyclosporine-treated renal transplant recipients.
    Brando B; Civati G; Busnach G; Grillo C; Minetti L
    Transplant Proc; 1984 Dec; 16(6):1639-41. PubMed ID: 6239430
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cyclosporin A].
    Lloveras Macià J
    Med Clin (Barc); 1984 Sep; 83(9):381-91. PubMed ID: 6390013
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive B cell crossmatches in highly sensitized patients--influence of antibody specificity on renal transplant outcome.
    Lazda VA; Pollak R; Mozes MF; Jonasson O
    Transplant Proc; 1987 Feb; 19(1 Pt 1):782-4. PubMed ID: 3547840
    [No Abstract]   [Full Text] [Related]  

  • 19. A functional assay for cyclosporine in patient serum.
    Orosz CG; Ferguson RM; Olson S; Ascher N
    Transplant Proc; 1984 Dec; 16(6):1624-5. PubMed ID: 6239428
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.